Canine Stem Cell Therapy Market Segmented By Allogeneic Stem Cells, Autologous Stem cells for Arthritis, Dysplasia, Tendonitis, Lameness
Industry: Healthcare
Published Date: April-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 230
Report ID: PMRREP15550
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Canine Stem Cell Therapy Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Evolution of Stem Cell Therapy In Veterinary
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity Analysis
4.3. Regulatory Scenario
5. Key Inclusions
5.1. Key Manufacturer List
5.2. Pricing Analysis
6. North America Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
6.4.1. Autologous Stem Cell
6.4.2. Allogeneic Stem Cell
6.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
6.6.1. Arthritis
6.6.2. Lameness
6.6.3. Dysplasia
6.6.4. Tendonitis
6.6.5. Others
6.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
6.8.1. Veterinary Hospitals
6.8.2. Veterinary Clinics
6.8.3. Veterinary Research Institutes
6.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
6.10. Drivers and Restraints: Impact Analysis
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Product Type
6.11.3. By Application
6.11.4. By End User
6.12. Key Takeaways
7. Latin America Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012-2016
7.2.1. Argentina
7.2.2. Brazil
7.2.3. Mexico
7.2.4. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
7.4.1. Autologous Stem Cell
7.4.2. Allogeneic Stem Cell
7.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
7.6.1. Arthritis
7.6.2. Lameness
7.6.3. Dysplasia
7.6.4. Tendonitis
7.6.5. Others
7.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
7.8.1. Veterinary Hospitals
7.8.2. Veterinary Clinics
7.8.3. Veterinary Research Institutes
7.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
7.10. Drivers and Restraints: Impact Analysis
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product Type
7.11.3. By Application
7.11.4. By End User
7.12. Key Takeaways
8. Europe Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
8.4.1. Autologous Stem Cell
8.4.2. Allogeneic Stem Cell
8.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
8.6.1. Arthritis
8.6.2. Lameness
8.6.3. Dysplasia
8.6.4. Tendonitis
8.6.5. Others
8.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
8.8.1. Veterinary Hospitals
8.8.2. Veterinary Clinics
8.8.3. Veterinary Research Institutes
8.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
8.10. Drivers and Restraints: Impact Analysis
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Product Type
8.11.3. By Application
8.11.4. By End User
8.12. Key Takeaways
9. APEJ Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
9.2.1. Japan
9.2.2. India
9.2.3. Australia and New Zealand
9.2.4. Rest of APEJ
9.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
9.4.1. Autologous Stem Cell
9.4.2. Allogeneic Stem Cell
9.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
9.6.1. Arthritis
9.6.2. Lameness
9.6.3. Dysplasia
9.6.4. Tendonitis
9.6.5. Others
9.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
9.8.1. Veterinary Hospitals
9.8.2. Veterinary Clinics
9.8.3. Veterinary Research Institutes
9.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
9.10. Drivers and Restraints: Impact Analysis
9.11. Market Attractiveness Analysis
9.11.1. By Country
9.11.2. By Product Type
9.11.3. By Application
9.11.4. By End User
9.12. Key Takeaways
10. Japan Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
10.2.1. Autologous Stem Cell
10.2.2. Allogeneic Stem Cell
10.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
10.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
10.4.1. Arthritis
10.4.2. Lameness
10.4.3. Dysplasia
10.4.4. Tendonitis
10.4.5. Others
10.5. Market Size (US$ Mn) Forecast By Application, 2017-2025
10.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
10.6.1. Veterinary Hospitals
10.6.2. Veterinary Clinics
10.6.3. Veterinary Research Institutes
10.7. Market Size (US$ Mn) Forecast By End User, 2017-2025
10.8. Drivers and Restraints: Impact Analysis
10.9. Market Attractiveness Analysis
10.9.1. By Product Type
10.9.2. By Application
10.9.3. By End User
10.10. Key Takeaways
11. Middle East & Africa Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
11.2.1. GCC Countries
11.2.2. South Africa
11.2.3. Rest of MEA
11.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
11.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
11.4.1. Autologous Stem Cell
11.4.2. Allogeneic Stem Cell
11.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
11.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
11.6.1. Arthritis
11.6.2. Lameness
11.6.3. Dysplasia
11.6.4. Tendonitis
11.6.5. Others
11.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
11.8.1. Veterinary Hospitals
11.8.2. Veterinary Clinics
11.8.3. Veterinary Research Institutes
11.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
11.10. Drivers and Restraints: Impact Analysis
11.11. Market Attractiveness Analysis
11.11.1. By Country
11.11.2. By Product Type
11.11.3. By Application
11.11.4. By End User
11.12. Key Takeaways
12. Forecast Factors: Relevance and Impact
13. Forecast Assumptions
14. Company Profiles
14.1. Company Deep Dive
14.1.1. VETSTEM BIOPHARMA
14.1.1.1. Overview
14.1.1.2. Product and Application Portfolio
14.1.1.3. Production Footprint
14.1.1.4. Sales Footprint
14.1.1.5. Channel Footprint
14.1.1.6. Strategy
14.1.1.6.1. Marketing Strategy
14.1.1.6.2. Product Strategy
14.1.1.6.3. Channel Strategy
14.1.2. Aratana Therapeutics
14.1.2.1. Overview
14.1.2.2. Product and Application Portfolio
14.1.2.3. Production Footprint
14.1.2.4. Sales Footprint
14.1.2.5. Channel Footprint
14.1.2.6. Strategy
14.1.2.6.1. Marketing Strategy
14.1.2.6.2. Product Strategy
14.1.2.6.3. Channel Strategy
14.1.3. Medivet Biologics LLC
14.1.3.1. Overview
14.1.3.2. Product and Application Portfolio
14.1.3.3. Production Footprint
14.1.3.4. Sales Footprint
14.1.3.5. Channel Footprint
14.1.3.6. Strategy
14.1.3.6.1. Marketing Strategy
14.1.3.6.2. Product Strategy
14.1.3.6.3. Channel Strategy
14.1.4. Okyanos
14.1.4.1. Overview
14.1.4.2. Product and Application Portfolio
14.1.4.3. Production Footprint
14.1.4.4. Sales Footprint
14.1.4.5. Channel Footprint
14.1.4.6. Strategy
14.1.4.6.1. Marketing Strategy
14.1.4.6.2. Product Strategy
14.1.4.6.3. Channel Strategy
14.1.5. Vetbiologics
14.1.5.1. Overview
14.1.5.2. Product and Application Portfolio
14.1.5.3. Production Footprint
14.1.5.4. Sales Footprint
14.1.5.5. Channel Footprint
14.1.5.6. Strategy
14.1.5.6.1. Marketing Strategy
14.1.5.6.2. Product Strategy
14.1.5.6.3. Channel Strategy
14.1.6. VetMatrix
14.1.6.1. Overview
14.1.6.2. Product and Application Portfolio
14.1.6.3. Production Footprint
14.1.6.4. Sales Footprint
14.1.6.5. Channel Footprint
14.1.6.6. Strategy
14.1.6.6.1. Marketing Strategy
14.1.6.6.2. Product Strategy
14.1.6.6.3. Channel Strategy
14.1.7. Magellan Stem Cells
14.1.7.1. Overview
14.1.7.2. Product and Application Portfolio
14.1.7.3. Production Footprint
14.1.7.4. Sales Footprint
14.1.7.5. Channel Footprint
14.1.7.6. Strategy
14.1.7.6.1. Marketing Strategy
14.1.7.6.2. Product Strategy
14.1.7.6.3. Channel Strategy
14.1.8. ANIMAL CELL THERAPIES, INC
14.1.8.1. Overview
14.1.8.2. Product and Application Portfolio
14.1.8.3. Production Footprint
14.1.8.4. Sales Footprint
14.1.8.5. Channel Footprint
14.1.8.6. Strategy
14.1.8.6.1. Marketing Strategy
14.1.8.6.2. Product Strategy
14.1.8.6.3. Channel Strategy
14.1.9. stemcellvet.co.uk
14.1.9.1. Overview
14.1.9.2. Product and Application Portfolio
14.1.9.3. Production Footprint
14.1.9.4. Sales Footprint
14.1.9.5. Channel Footprint
14.1.9.6. Strategy
14.1.9.6.1. Marketing Strategy
14.1.9.6.2. Product Strategy
14.1.9.6.3. Channel Strategy
14.1.10. Cell Therapy Sciences
14.1.10.1. Overview
14.1.10.2. Product and Application Portfolio
14.1.10.3. Production Footprint
14.1.10.4. Sales Footprint
14.1.10.5. Channel Footprint
14.1.10.6. Strategy
14.1.10.6.1. Marketing Strategy
14.1.10.6.2. Product Strategy
14.1.10.6.3. Channel Strategy
14.1.11. Regeneus Ltd.
14.1.11.1. Overview
14.1.11.2. Product and Application Portfolio
14.1.11.3. Production Footprint
14.1.11.4. Sales Footprint
14.1.11.5. Channel Footprint
14.1.11.6. Strategy
14.1.11.6.1. Marketing Strategy
14.1.11.6.2. Product Strategy
14.1.11.6.3. Channel Strategy
15. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025, By Region
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012-2016
15.3. Market Size (US$ Mn) Forecast By Region, 2017-2025
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. APEJ
15.3.5. Middle East & Africa
15.3.6. Japan
15.4. Market Attractiveness Analysis By Region
16. Global Canine Stem Cell Therapy Analysis 2012-2016 and Forecast 2017-2025, By Product Type
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
16.2.1. Autologous Stem Cell
16.2.2. Allogeneic Stem Cell
16.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
16.4. Market Attractiveness Analysis By Product Type
17. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025, By Application
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
17.2.1. Arthritis
17.2.2. Lameness
17.2.3. Dysplasia
17.2.4. Tendonitis
17.2.5. Others
17.3. Market Size (US$ Mn) Forecast By Application, 2017-2025
17.4. Market Attractiveness Analysis By Application
18. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025, By End User
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
18.2.1. Veterinary Hospitals
18.2.2. Veterinary Clinics
18.2.3. Veterinary Research Institutes
18.3. Market Size (US$ Mn) Forecast By End User, 2017-2025
18.4. Market Attractiveness Analysis By End User
19. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025
19.1. Market Value Share Analysis By All Segment
19.2. Y-o-Y Growth Analysis By All Segment
19.3. Absolute $ Opportunity
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Global Key Company and Product Mapping
Table 02: Canine Stem Cell Therapy Average Cost (US$/Therapy), By Product Type
Table 03: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
Table 04: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
Table 05: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 06: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
Table 07: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
Table 08: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
Table 09: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 10: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
Table 11: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
Table 12: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
Table 13: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 14: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
Table 15: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
Table 16: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
Table 17: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 18: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
Table 19: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
Table 20: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 21: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
Table 22: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
Table 23: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
Table 24: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 25: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
Table 26: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Region
Table 27: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product Type
Table 28: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
Table 29: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End Use
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Canine Stem Cell Therapy Market Revenue Share by Product Type 2018E & 2026F
Figure 02: Canine Stem Cell Therapy Market Revenue Share by End User, 2018E & 2026F
Figure 03: Global Market Value Share 2018E, By Application Type
Figure 04: Global Canine Stem Cell Market Revenue Opportunity Analysis, By Region 2018-2026
Figure 05: U.S. Estimated Breakdown of Pet Industry Expenditure (US$ Bn), By Service 2017
Figure 06: Total U.S. Pet Industry Expenditures (US$ Bn), 2017
Figure 07: U.S. Consumer Spending (US$ Bn) on Veterinary Care
Figure 08: Global Canine Stem Cell Therapy Average Price, 2017 - 2020
Figure 09: North America Canine Stem Cell Therapy Market Value Share (2017A)
Figure 10: North America Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 11: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 12: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 13: U.S. Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 14: U.S. Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 15: Canada Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 16: Canada Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 17: North America Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 18: North America Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 19: North America Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 20: North America Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 21: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
Figure 22: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
Figure 23: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
Figure 24: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
Figure 25: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 26: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 27: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
Figure 28: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
Figure 29: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
Figure 30: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
Figure 31: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 32: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 33: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 34: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 35: Latin America Canine Stem Cell Therapy Market Value Share (2017A)
Figure 36: Latin America Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 37: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 38: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 39: Brazil Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 40: Brazil Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 41: Mexico Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 42: Mexico Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 43: Rest of Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 44: Rest of Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 45: Latin America Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 46: Latin America Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 47: Latin America Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 48: Latin America Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 49: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
Figure 50: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
Figure 51: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
Figure 52: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
Figure 53: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 54: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 55: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
Figure 56: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
Figure 57: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
Figure 58: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
Figure 59: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 60: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 61: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 62: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 63: Europe Canine Stem Cell Therapy Market Value Share (2017A)
Figure 64: Europe Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 65: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 66: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 67: Germany Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 68: Germany Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 69: U.K. Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 70: U.K. Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 71: France Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 72: France Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 73: Italy Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 74: Italy Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 75: Spain Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 76: Spain Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 77: Russia Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 78: Russia Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 79: Rest of Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 80: Rest of Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 81: Europe Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 82: Europe Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 83: Europe Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 84: Europe Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 85: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
Figure 86: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
Figure 87: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
Figure 88: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
Figure 89: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 90: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 91: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
Figure 92: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
Figure 93: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
Figure 94: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
Figure 95: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 96: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 97: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 98: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 99: APEJ Canine Stem Cell Therapy Market Value Share (2017A)
Figure 100: APEJ Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 101: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 102: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 103: India Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 104: India Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 105: Australia & New Zealand Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 106: Australia & New Zealand Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 107: Rest of APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 108: Rest of APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 109: APEJ Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 110: APEJ Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 111: APEJ Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 112: APEJ Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 113: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
Figure 114: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
Figure 115: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
Figure 116: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
Figure 117: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 118: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 119: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
Figure 120: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
Figure 121: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
Figure 122: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
Figure 123: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 124: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 125: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 126: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 127: Japan Canine Stem Cell Therapy Market Value Share (2017A)
Figure 128: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 129: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 130: Japan Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 131: Japan Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 132: Japan Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 133: Japan Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 134: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
Figure 135: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
Figure 136: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
Figure 137: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
Figure 138: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 139: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 140: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
Figure 141: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
Figure 142: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 143: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 144: Asia Pacific Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 145: Japan Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 146: Japan Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 147: Middle East & Africa Canine Stem Cell Therapy Market Value Share (2017A)
Figure 148: Middle East & Africa Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 149: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 150: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 151: GCC Countries Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 152: GCC Countries Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 153: South Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 154: South Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 155: Rest of Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 156: Rest of Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 157: Middle East & Africa Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 158: Middle East & Africa Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 159: Middle East & Africa Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
Figure 160: Middle East & Africa Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 161: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
Figure 162: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
Figure 163: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
Figure 164: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
Figure 165: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
Figure 166: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
Figure 167: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
Figure 168: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
Figure 169: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
Figure 170: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
Figure 171: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 172: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 173: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 174: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 175: Global Canine Stem Cell Therapy Market Share Analysis (%) By Region, 2018 & 2026
Figure 176: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Region, 2018-2026
Figure 177: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Region, 2018-2026
Figure 178: Global Canine Stem Cell Therapy Market Share Analysis (%) By Product Type, 2018 & 2026
Figure 179: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Product Type, 2018-2026
Figure 180: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Product Type, 2018-2026
Figure 181: Global Canine Stem Cell Therapy Market Share Analysis (%) By Application, 2018 & 2026
Figure 182: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Application, 2018-2026
Figure 183: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Application, 2018-2026
Figure 184: Global Canine Stem Cell Therapy Market Share Analysis (%) By End User, 2018 & 2026
Figure 185: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By End User, 2018-2026
Figure 186: Global Canine Stem Cell Therapy Market Attractiveness Analysis By End User, 2018-2026
Figure 187: Global Canine Stem Cell Therapy Market Value Analysis and Forecast, 2017-2026 (US$ Mn)
Figure 188: Global Canine Stem Cell Therapy Market Value (US$ Mn), 2014-2017
Figure 189: Global Canine Stem Cell Therapy Market Absolute $ Opportunity (US$ Mn), 2017-2026
